Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
International Journal of Biological Macromolecules|August 8, 2025
Epigenetically regulated ZCCHC9 plays a pro-tumorigenic role in glioma based on a multi-omics analysisZhifeng Lin, Jinghan Zhang, Yufang Li, et al.
International Journal of Oncology|February 16, 2017
SIRT3 is correlated with the malignancy of non-small cell lung cancerYanlu Xiong, Mingxing Wang, Jinbo Zhao, et al.
International Journal of Cancer|May 22, 2019
Sp1-mediated epigenetic dysregulation dictates HDAC inhibitor susceptibility of HER2-overexpressing breast cancerGuoyin Li, Qiaosheng Xie, Zhiwei Yang, et al.
Frontiers in Immunology|February 22, 2021
TGF-β Signaling Promotes Glioma Progression Through Stabilizing Sox9Min Chao, Nan Liu, Zhichuan Sun, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 21, 2026
UFMylation at the Crossroads of Health and Cancer: A Blessing in DisguiseCongcong Li, Daixing Zhong, Yuqian Ma, et al.
Journal of Cellular and Molecular Medicine|July 16, 2008
IL-12 immunotherapy of murine leukaemia: comparison of systemic versus gene modified cell therapyAlain Labbe, Megan Nelles, Jagdeep Walia, et al.
BMB Reports|November 30, 2013
MiR-221 promotes trastuzumab-resistance and metastasis in HER2-positive breast cancers by targeting PTENXingming Ye, Wendong Bai, Huayu Zhu, et al.
Journal of Cancer Research and Clinical Oncology|November 6, 2017
SIRT3 deacetylates and promotes degradation of P53 in PTEN-defective non-small cell lung cancerYanlu Xiong, Lei Wang, Shan Wang, et al.
Signal Transduction and Targeted Therapy|June 23, 2021
Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumabGuoxu Zheng, Zhangyan Guo, Weimiao Li, et al.
Pageof 7